Skip to main content
TipRanks
Go Ultimate75% OFF

NRX Pharmaceuticals (NRXP) Ratios

1,029 Followers

NRX Pharmaceuticals Ratios

NRXP's free cash flow for Q2 2026 was $-9.77M. For the 2026 fiscal year, NRXP's free cash flow was decreased by $-897.00K and operating cash flow was $-8.88M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Mar 24Dec 22Mar 22
Liquidity Ratios
Current Ratio0.310.150.361.662.74
Quick Ratio0.310.150.361.662.74
Cash Ratio0.270.070.241.292.32
Solvency Ratio-0.99-0.93-1.58-2.16-7.81
Operating Cash Flow Ratio-0.49-0.49-1.14-2.55-3.16
Short-Term Operating Cash Flow Coverage0.00-6.79-2.36-5.16-72.79
Net Current Asset Value$ -20.00M$ -23.57M$ -12.16M$ 7.39M$ 20.79M
Leverage Ratios
Debt-to-Assets Ratio0.051.801.250.410.02
Debt-to-Equity Ratio-0.04-0.28-0.781.420.02
Debt-to-Capital Ratio-0.04-0.40-3.560.590.02
Long-Term Debt-to-Capital Ratio0.00-0.280.000.280.00
Financial Leverage Ratio-0.81-0.16-0.623.481.57
Debt Service Coverage Ratio-41.44-9.09-3.24-5.16-173.59
Interest Coverage Ratio-24.18-18.26-229.890.00-5288.94
Debt to Market Cap0.000.280.260.010.00
Interest Debt Per Share0.060.731.230.160.01
Net Debt to EBITDA0.26-0.21-0.150.240.29
Profitability Margins
Gross Profit Margin58.78%0.00%0.00%0.00%0.00%
EBIT Margin-2281.71%0.00%0.00%0.00%0.00%
EBITDA Margin-2270.04%0.00%0.00%0.00%0.00%
Operating Profit Margin-1324.41%0.00%0.00%0.00%0.00%
Pretax Profit Margin-2336.49%0.00%0.00%0.00%0.00%
Net Profit Margin-2336.49%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin-2336.49%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT176.42%127.52%109.29%89.67%97.75%
Return on Assets (ROA)-220.92%-688.20%-412.17%-153.99%-284.34%
Return on Equity (ROE)179.59%108.19%256.97%-536.56%-447.29%
Return on Capital Employed (ROCE)103.85%108.19%235.12%-433.34%-457.57%
Return on Invested Capital (ROIC)106.00%118.37%1072.59%-247.21%-446.45%
Return on Tangible Assets-279.57%-688.20%-412.17%-153.99%-284.34%
Earnings Yield-49.35%-108.59%-86.51%-5.45%-4.15%
Efficiency Ratios
Receivables Turnover7.610.000.000.000.00
Payables Turnover0.120.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover1.940.000.000.000.00
Asset Turnover0.090.000.000.000.00
Working Capital Turnover Ratio-0.060.000.000.000.00
Cash Conversion Cycle-3038.27-301490.00-338136.00-189435.00-672877.50
Days of Sales Outstanding47.970.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding3086.24301490.00338136.00189435.00672877.50
Operating Cycle47.970.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.66-1.01-2.86-0.60-0.80
Free Cash Flow Per Share-0.66-1.01-2.86-0.60-0.80
Dividend Paid and CapEx Coverage Ratio0.000.00-7219.00-3975.50-5386.14
Capital Expenditure Coverage Ratio0.000.00-7219.00-3975.50-5386.14
Operating Cash Flow Coverage Ratio-22.36-1.62-2.36-3.78-72.79
Operating Cash Flow to Sales Ratio-11.520.000.000.000.00
Free Cash Flow Yield-24.33%-45.97%-62.15%-5.45%-1.68%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-2.02-0.92-1.16-18.36-24.10
Price-to-Sales (P/S) Ratio47.350.000.000.000.00
Price-to-Book (P/B) Ratio-3.64-1.00-2.9798.53107.79
Price-to-Free Cash Flow (P/FCF) Ratio-4.11-2.18-1.61-18.36-59.47
Price-to-Operating Cash Flow Ratio-4.11-2.18-1.61-18.36-59.48
Price-to-Earnings Growth (PEG) Ratio0.050.02-0.000.20-0.06
Enterprise Value Multiple-1.83-1.18-1.31-18.13-23.81
Enterprise Value50.83M28.27M39.42M720.48M2.22B
EV to EBITDA-1.83-1.18-1.31-18.13-23.81
EV to Sales41.500.000.000.000.00
EV to Free Cash Flow-3.60-2.66-1.82-18.12-58.75
EV to Operating Cash Flow-3.60-2.66-1.82-18.12-58.76
Tangible Book Value Per Share-0.87-2.21-1.550.110.44
Shareholders’ Equity Per Share-0.74-2.21-1.550.110.44
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.060.000.000.000.00
Net Income Per Share-1.34-2.39-3.98-0.60-1.98
Tax Burden1.001.001.001.001.00
Interest Burden1.021.041.001.001.00
Research & Development to Revenue3.080.000.000.000.00
SG&A to Revenue10.660.000.000.000.00
Stock-Based Compensation to Revenue0.190.000.000.000.00
Income Quality0.490.420.721.000.41

Currency in USD